Nishan Tchekmedyian

Also affiliated with City of Hope

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib”.

Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100081

N/A

0DataRank · unranked

1 citations

Bill Paxton, François Lebel, Lena Keossayan, John V. Heymach, Nishan Tchekmedyian

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

Nature Communications(2025)10.1038/s41467-025-61817-8

N/A

0DataRank · unranked

7 citations

Jacqulyne Robichaux, Monique B. Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu +21 more